Aurintricarboxylic Acid: Inhibitor of Initiation of Protein Synthesis

  1. Margaret L. Stewart,
  2. Arthur P. Grollman*, and
  3. Mou-Tuan Huang*
  1. Department of Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461
  2. Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461
  3. Division of Biology, Department of Molecular Biology, Albert Einstein College of Medicine, Bronx, New York 10461

Abstract

Aurintricarboxylic acid prevents the attachment of bacteriophage messenger RNA to ribosomes. As a consequence, initiation of protein synthesis in cell-free extracts prepared from Escherichia coli or rabbit reticulocytes is inhibited at concentrations of dye that do not prevent chain extension. Its properties can be distinguished from other agents that inhibit protein synthesis, including sodium fluoride, cycloheximide, and pactamycin.

Footnotes

  • * Career Investigator of the Health Research Council of the City of New York.

« Previous | Next Article »Table of Contents